|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
multiple interactions |
ISO |
ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] |
CTD |
PMID:17018608 |
|
NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943
|
|
G |
Afp |
alpha fetoprotein |
multiple interactions |
ISO |
ebselen inhibits the reaction [Aflatoxin B1 results in increased expression of AFP mRNA] |
CTD |
PMID:11133813 |
|
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
|
|
G |
Alad |
aminolevulinate, delta-, dehydratase |
multiple interactions decreases activity |
ISO EXP |
Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein] ebselen inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein] |
CTD |
PMID:14630126 PMID:17624921 PMID:23933410 |
|
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases activity |
ISO |
ebselen results in decreased activity of ALOX5 protein |
CTD |
PMID:7590103 |
|
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in increased expression of BAX protein] |
CTD |
PMID:30558456 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:30558456 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP3 protein] ebselen inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; ebselen inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] ebselen results in increased activity of CASP3 protein |
CTD |
PMID:21300091 PMID:23649643 PMID:25068500 PMID:30558456 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] |
CTD |
PMID:18629305 PMID:23649643 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
ISO |
ebselen results in increased activity of CAT protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] |
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4I1 |
increases expression |
ISO |
ebselen results in increased expression of COX4I1 protein |
CTD |
PMID:27385396 |
|
NCBI chr 8:121,394,964...121,400,948
Ensembl chr 8:121,394,961...121,400,946
|
|
G |
Cs |
citrate synthase |
multiple interactions |
ISO |
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] ebselen inhibits the reaction [Cisplatin results in decreased activity of CS protein] |
CTD |
PMID:27385396 PMID:32860823 |
|
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; ebselen inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL8 protein]; ebselen inhibits the reaction [Peroxynitrous Acid results in increased expression of CXCL8 mRNA]; ebselen inhibits the reaction [Peroxynitrous Acid results in increased expression of CXCL8 protein] |
CTD |
PMID:14572605 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:27282967 |
|
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
|
|
G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of EPHX2 protein |
CTD |
PMID:23219563 |
|
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] |
CTD |
PMID:27385396 |
|
NCBI chr X:67,722,144...67,761,569
Ensembl chr X:67,722,147...67,761,569
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
ISO |
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein] |
CTD |
PMID:14572605 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Cisplatin results in increased activity of G6PC1 protein] |
CTD |
PMID:32860823 |
|
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
|
|
G |
Gck |
glucokinase |
multiple interactions |
EXP |
[ebselen co-treated with Glucose] results in increased activity of GCK protein |
CTD |
PMID:23795780 |
|
NCBI chr11:5,850,816...5,900,081
Ensembl chr11:5,850,820...5,900,081
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of GFAP protein |
CTD |
PMID:27282967 |
|
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein] |
CTD |
PMID:12958040 |
|
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP ISO |
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] ebselen inhibits the reaction [Methylmercury Compounds results in decreased activity of GPX1 protein] |
CTD |
PMID:23795780 PMID:28383113 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gsr |
glutathione reductase |
increases activity multiple interactions |
ISO |
ebselen results in increased activity of GSR protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] |
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
Gstm2 |
glutathione S-transferase, mu 2 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of GSTP1 protein |
CTD |
PMID:8147899 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
multiple interactions |
ISO |
ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]] |
CTD |
PMID:19374849 |
|
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[ebselen affects the abundance of Reactive Oxygen Species] which results in decreased expression of HMOX1 protein; [ebselen affects the abundance of Reactive Oxygen Species] which results in increased activity of HMOX1 protein |
CTD |
PMID:16959961 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
increases expression |
EXP |
ebselen results in increased expression of HPGDS mRNA |
CTD |
PMID:21669866 |
|
NCBI chr 6:65,094,019...65,121,960
Ensembl chr 6:65,094,277...65,121,892
|
|
G |
Hsf1 |
heat shock factor 1 |
increases activity |
ISO |
ebselen results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:12794164 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in increased expression of IL6 protein] |
CTD |
PMID:30558456 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
multiple interactions |
EXP |
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:23795780 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation increases activity |
EXP ISO |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen analog results in increased phosphorylation of MAPK1 protein; ebselen results in increased phosphorylation of MAPK1 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen results in increased activity of MAPK1 protein |
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation increases activity |
EXP ISO |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen analog results in increased phosphorylation of MAPK3 protein; ebselen results in increased phosphorylation of MAPK3 protein ebselen results in increased activity of MAPK3 protein |
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27282967 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP13 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 |
|
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions decreases activity |
EXP ISO |
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] ebselen results in decreased activity of NOS2 protein |
CTD |
PMID:7590103 PMID:12794164 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
decreases activity |
ISO |
ebselen results in decreased activity of NQO1 protein |
CTD |
PMID:7590103 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions |
EXP |
[ebselen co-treated with Glucose] results in increased expression of PDX1 protein |
CTD |
PMID:23795780 |
|
NCBI chr 5:147,206,907...147,212,658
Ensembl chr 5:147,206,769...147,212,658
|
|
G |
Phospho1 |
phosphatase, orphan 1 |
decreases activity |
ISO |
ebselen results in decreased activity of PHOSPHO1 protein |
CTD |
PMID:17227223 |
|
NCBI chr11:95,715,326...95,722,966
Ensembl chr11:95,715,325...95,722,966
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein] |
CTD |
PMID:14572605 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
multiple interactions |
ISO |
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] |
CTD |
PMID:16984886 |
|
NCBI chr15:100,285,779...100,322,090
Ensembl chr15:100,285,779...100,322,953
|
|
G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
multiple interactions |
EXP ISO |
[ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein ebselen inhibits the reaction [Cisplatin results in increased expression of SLC2A2 protein] |
CTD |
PMID:23795780 PMID:32860823 |
|
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:21131394 |
|
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
decreases response to substance multiple interactions |
ISO EXP |
ebselen results in decreased susceptibility to SOD1 protein mutant form ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:16702190 PMID:23795780 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions |
ISO |
ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
ISO |
ebselen inhibits the reaction [Cisplatin results in increased activity of TAT protein] |
CTD |
PMID:32860823 |
|
NCBI chr 8:110,712,710...110,726,436
Ensembl chr 8:110,717,069...110,726,435
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:11903743 PMID:16757516 PMID:21131394 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
ebselen inhibits the reaction [sodium arsenite results in increased expression of TNF protein] |
CTD |
PMID:30558456 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
ebselen results in increased expression of and results in increased activity of TXNRD1 protein |
CTD |
PMID:28383113 |
|
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
|
|
G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
multiple interactions |
EXP |
[ebselen co-treated with Glucose] results in decreased expression of UCP2 protein |
CTD |
PMID:23795780 |
|
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases phosphorylation |
ISO |
ebselen results in increased phosphorylation of XBP1 protein |
CTD |
PMID:27282967 |
|
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
|
|
G |
Xpa |
xeroderma pigmentosum, complementation group A |
multiple interactions |
ISO |
ebselen inhibits the reaction [Zinc binds to XPA protein] |
CTD |
PMID:15265038 |
|
NCBI chr 4:46,175,222...46,196,317
Ensembl chr 4:46,155,347...46,196,311
|
|